Cargando…
What Percentage of Patients with Duchene Muscular Dystrophy are Potentially Treatable with Gene Therapies?
Autores principales: | Passi, Gouri Rao, Paharia, Manjari, Jaiswal, Shree Prakash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513967/ https://www.ncbi.nlm.nih.gov/pubmed/34728964 http://dx.doi.org/10.4103/aian.AIAN_806_20 |
Ejemplares similares
-
Treatment with Ataluren for Duchene Muscular
Dystrophy
por: Morkous, Sameh S.
Publicado: (2020) -
Prevalence Study of Duchene Muscular Dystrophy and its Genetic Sequence in Southern India
por: SATTENAPALLI, Nigama Chandra, et al.
Publicado: (2023) -
Study of Clinical Features and Diagnosis Pattern of Duchene Muscular Dystrophy in Southern India
por: Sattenapalli, Nigama Chandra, et al.
Publicado: (2022) -
Exon Deletion Pattern in Duchene Muscular Dystrophy in North West of Iran
por: BARZEGAR, Mohammad, et al.
Publicado: (2015) -
Efficacy of two intervention approaches on functional walking capacity and balance in children with Duchene muscular dystrophy
por: Sherief, Abd El Aziz A., et al.
Publicado: (2021)